Suchergebnisse - "Guarneri, Valentina"

PubPharm (313)

1

The study of primary and acquired resistance to first-line osimertinib to improve the outcome of EGFR-mutated advanced Non-small cell lung cancer patients : the challenge is open for new therapeutic strategies

enthalten in: Critical reviews in oncology/hematology | 2024

von Ferro, A. | Marinato, G. | Mulargiu, C. | +4

2

Study design for DESTINY-Breast Respond HER2-low Europe : T-DXd in patients with HER2-low advanced breast cancer

enthalten in: Future oncology (London, England) | 2024

von Guarneri, V. | Passos Coelho, J. | Duhoux, F. | +9

3

Corrigendum to "Breaking barriers in triple negative breast cancer (TNBC) - Unleashing the power of antibody-drug conjugates (ADCs)" [Cancer Treatment Reviews 123 (2024) 102672

enthalten in: Cancer treatment reviews | 2024

von Dri, A. | Arpino, G. | Bianchini, G. | +12

ErratumFor: Cancer Treat Rev. 2024 Feb;123:102672. - PMID 38118302

4

Osimertinib in Patients With Treatment-Naive EGFR-Mutant Non-small Cell Lung Cancer : Overall Survival, Post-progression Management and Budget Impact Analysis in Real-World

enthalten in: The oncologist | 2024

von Pasello, G. | Lorenzi, M. | Scattolin, D. | +16

5

Accessible Machine Learning and Deep Learning Models Predict Response and Survival in Early Stage Hormone Receptor-Positive/HER2-Negative Breast Cancer Receiving Neoadjuvant Chemotherapy

enthalten in: ResearchSquare.com | 2024

von Garufi, G. | Mastrantoni, L. | Giordano, G. | +27

6

Gender minorities in breast cancer - Clinical trials enrollment disparities : Focus on male, transgender and gender diverse patients

enthalten in: Breast (Edinburgh, Scotland) | 2024

von Miglietta, F. | Pontolillo, L. | De Angelis, C. | +16

7

Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients

enthalten in: Journal of translational medicine | 2024

von Pasello, G. | Fabricio, A. | Del Bianco, P. | +15

8

Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients

enthalten in: Journal of translational medicine | 2024

von Pasello, G. | Fabricio, A. | Del Bianco, P. | +15

9

Clinical effectiveness and safety of olaparib in BRCA-mutated, HER2-negative metastatic breast cancer in a real-world setting : final analysis of LUCY

enthalten in: Breast cancer research and treatment | 2024

von Balmaña, J. | Fasching, P. | Couch, F. | +123

10

Long-term patient-reported outcomes from monarchE : Abemaciclib plus endocrine therapy as adjuvant therapy for HR+, HER2-, node-positive, high-risk, early breast cancer

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Tolaney, S. | Guarneri, V. | Seo, J. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[32]